{"id":770848,"date":"2019-02-06T17:04:02","date_gmt":"2019-02-06T15:04:02","guid":{"rendered":""},"modified":"2019-02-06T17:04:02","modified_gmt":"2019-02-06T15:04:02","slug":"redcliffe-partners-vystupyla-radnykom-cvc-dlya-otrymannya-dozvolu-amku-na-kontsentratsiyu","status":"publish","type":"post","link":"https:\/\/new.eba.com.ua\/en\/redcliffe-partners-vystupyla-radnykom-cvc-dlya-otrymannya-dozvolu-amku-na-kontsentratsiyu\/","title":{"rendered":"Redcliffe Partners advised CVC on obtaining merger clearance in Ukraine"},"content":{"rendered":"<p>Redcliffe Partners advised CVC on obtaining merger clearance from the Ukrainian competition authority for its acquisition of Recordati S.p.A. (Recordati). The deal is valued at approximately EUR 3 billion. Through its expertise and global healthcare network CVC will expand Recordati\u2019s rare disease business and accelerate its growth strategy as a leading global company in the pharmaceutical industry.<\/p>\n<p>Redcliffe\u2019s team working on the transaction consisted of counsel <strong>Anastasia Usova<\/strong>, senior associate <strong>Nataliya Kovalyova<\/strong> and associate <strong>Tetyana Smurova<\/strong>.<\/p>\n<p style=\"text-align: center;\">* * *<\/p>\n<p>CVC is a world leader in private equity and comprises 24 offices globally, making it one of the most geographically diverse and longest established networks of any private equity investor worldwide.<\/p>\n<p>Recordati is an international pharmaceutical group, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. The Recordati Group offers a wide range of innovative pharmaceuticals in a number of therapeutic areas including a specialised segment dedicated to treatments for rare diseases.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Redcliffe Partners advised CVC on obtaining merger clearance from the Ukrainian competition authority for its acquisition of Recordati S.p.A. (Recordati). The deal is valued at approximately EUR 3 billion. Through its expertise and global healthcare network CVC will expand Recordati\u2019s rare disease business and accelerate its growth strategy as a leading global company in the [&hellip;]<\/p>\n","protected":false},"author":4489,"featured_media":163322,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[15576,15575],"tags":[],"class_list":["post-770848","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-and-articles-en","category-news-and-articles-from-companies-en","company-17084"],"_links":{"self":[{"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/posts\/770848","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/users\/4489"}],"replies":[{"embeddable":true,"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/comments?post=770848"}],"version-history":[{"count":0,"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/posts\/770848\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/media\/163322"}],"wp:attachment":[{"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/media?parent=770848"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/categories?post=770848"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/tags?post=770848"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}